BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 3156560)

  • 1. Tissue and blood T-lymphocyte subpopulations in erythema nodosum leprosum.
    Modlin RL; Bakke AC; Vaccaro SA; Horwitz DA; Taylor CR; Rea TH
    Arch Dermatol; 1985 Feb; 121(2):216-9. PubMed ID: 3156560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ characterization of T lymphocyte subsets in the reactional states of leprosy.
    Modlin RL; Gebhard JF; Taylor CR; Rea TH
    Clin Exp Immunol; 1983 Jul; 53(1):17-24. PubMed ID: 6223731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in predominant T cell phenotypes and distribution pattern in reactional lesions of tuberculoid and lepromatous leprosy.
    Narayanan RB; Laal S; Sharma AK; Bhutani LK; Nath I
    Clin Exp Immunol; 1984 Mar; 55(3):623-8. PubMed ID: 6423326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral blood T lymphocyte subsets in leprosy.
    Rea TH; Bakke AC; Parker JW; Modlin RL; Horwitz DA
    Int J Lepr Other Mycobact Dis; 1984 Sep; 52(3):311-7. PubMed ID: 6332790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tr, T mu and B lymphocytes in erythema nodosum leprosum reactions of leprosy.
    Rao TD; Rao PR
    Indian J Lepr; 1986; 58(4):601-8. PubMed ID: 2952738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ demonstration of T lymphocyte subsets in granulomatous inflammation: leprosy, rhinoscleroma and sarcoidosis.
    Modlin RL; Hofman FM; Meyer PR; Sharma OP; Taylor CR; Rea TH
    Clin Exp Immunol; 1983 Mar; 51(3):430-8. PubMed ID: 6221839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A follow up of T-cell subsets and of anti-M. leprae antibody titer as measured by the FLA-ABS test in Melanesian leprosy patients under polychemotherapy.
    Garraud O; Ribierre O; Bach MA
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):38-45. PubMed ID: 2940306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imbalances in T cell subpopulations in lepromatous leprosy.
    Wallach D; Cottenot F; Bach MA
    Int J Lepr Other Mycobact Dis; 1982 Sep; 50(3):282-90. PubMed ID: 6216219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ identification of activated Ta1+ T lymphocytes in human leprosy skin lesions.
    Shen JY; Hofman FM; Gunter JR; Modlin RL; Rea TH
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):494-8. PubMed ID: 2443587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on T cell subsets and functions in leprosy.
    Bach MA; Chatenoud L; Wallach D; Phan Dinh Tuy F; Cottenot F
    Clin Exp Immunol; 1981 Jun; 44(3):491-500. PubMed ID: 6459897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymus dependent lymphocytes in leprosy. I. T lymphocyte subpopulations defined by monoclonal antibodies.
    Mshana RN; Haregewoin A; Harboe M; Belehu A
    Int J Lepr Other Mycobact Dis; 1982 Sep; 50(3):291-6. PubMed ID: 6216220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ConA-induced suppressor cells in lepromatous leprosy patients during and after erythema nodosum leprosum.
    Sasiain MC; Ruibal Ares B; BaliƱa LM; Valdez R; Bachmann AE
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):321-7. PubMed ID: 6227570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ and in vitro characterization of the cellular immune response in erythema nodosum leprosum.
    Modlin RL; Mehra V; Jordan R; Bloom BR; Rea TH
    J Immunol; 1986 Feb; 136(3):883-6. PubMed ID: 2416837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: I. Quantitative analysis of peripheral blood lymphocytes.
    Faure M; Thivolet J
    J Clin Immunol; 1982 Jul; 2(3 Suppl):103S-110S. PubMed ID: 6215423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressor cell activity and phenotypes in the blood or tissues of patients with leprosy.
    Rea TH
    Clin Exp Immunol; 1983 Nov; 54(2):298-304. PubMed ID: 6228349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image Morphometric Analysis of B Cells and Plasma Cells in Erythema Nodosum Leprosum With Clinicopathological Correlation.
    Biswas D; Sethy M; Behera B; Palit A; Mitra S
    Am J Dermatopathol; 2021 Oct; 43(10):700-706. PubMed ID: 33264135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with erythema nodosum leprosum lack T-suppressor cells.
    Wallach D; Flageul B; Cottenot F; Bach MA
    Arch Dermatol; 1985 Nov; 121(11):1379. PubMed ID: 2932061
    [No Abstract]   [Full Text] [Related]  

  • 18. Simultaneous upgrading reaction and erythema nodosum leprosum in a patient with lepromatous leprosy.
    Job CK; Jacobson RR; Hastings RC
    Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):437-42. PubMed ID: 3418207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cyclosporine A in erythema nodosum leprosum.
    Uyemura K; Dixon JF; Wong L; Rea TH; Modlin RL
    J Immunol; 1986 Dec; 137(11):3620-3. PubMed ID: 2946765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 1 reactions in leprosy--heterogeneity in T-cell functions related to the background leprosy type.
    Laal S; Mishra RS; Nath I
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):481-93. PubMed ID: 2958570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.